Brentuximab vedotinFirst reports of diarrhoea, neutropenia, elevated ALT, hypophosphataemia, and peripheral neuropathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1402卷 / 1期

关键词：

Clinical Trial; Lymphoma; Neuropathy; Patient Outcome; Neutropenia;

D O I：

10.2165/00128415-201214020-00041

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：13 / 13

相关论文

共 50 条

[1] IrinotecanFebrile neutropenia, diarrhoea and peripheral neuropathy: 2 case reports
Reactions Weekly, 2017, 1666 (1) : 167 - 167
[2] Brentuximab vedotinDeteriorating peripheral neuropathy: case report
Reactions Weekly, 2017, 1650 (1) : 72 - 72
[3] Brentuximab vedotinWorsening of peripheral neuropathy: case report
Reactions Weekly, 2016, 1583 (1) : 226 - 226
[4] Brentuximab vedotinFirst report of cytokine release syndrome: case report
Reactions Weekly, 2015, 1555 (1) : 41 - 41
[5] Brentuximab vedotinFirst report of toxic epidermal necrolysis: case report
Reactions Weekly, 2015, 1577 (1) : 68 - 68
[6] NivolumabCardiotoxicity, neutropenia and peripheral neuropathy: 3 case reports
Reactions Weekly, 2021, 1853 (1) : 361 - 361
[7] Brentuximab-vedotinFatigue and peripheral neuropathy: case report
Reactions Weekly, 2025, 2050 (1) : 126 - 126
[8] Brentuximab vedotinPhlebitis and peripheral sensory neuropathy: case report
Reactions Weekly, 2019, 1784 (1) : 69 - 69
[9] AntineoplasticsSensory peripheral neuropathy and neutropenia: case report
Reactions Weekly, 2018, 1701 (1) : 33 - 33
[10] Gemcitabine/paclitaxelFebrile neutropenia and peripheral neuropathy: 2 case reports
Reactions Weekly, 2021, 1881 (1) : 125 - 125

← 1 2 3 4 5 →